Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 106 peer-reviewed journal articles Updated
Hematology · Myelodysplastic Syndromes

Myelodysplastic Syndromes (MDS) Resource Guide

At a Glance

Myelodysplastic Syndromes (MDS), now officially called Myelodysplastic Neoplasms, are a group of bone marrow disorders. This comprehensive guide helps patients understand their specific subtype, decode their pathology report, calculate their IPSS-M risk score, and navigate treatment options.

Welcome to your comprehensive guide on Myelodysplastic Syndromes (MDS)—now officially updated and classified by medical experts as Myelodysplastic Neoplasms.

Being diagnosed with MDS can feel like stepping into a confusing, highly technical new world. The terminology is dense, the statistics can be frightening, and the “watch and wait” approach often feels counterintuitive. This guide was created to help you regain control. It translates the latest medical guidelines, genetic discoveries, and treatment strategies into plain, actionable language.

You do not need to read this guide all at once. We recommend starting with the basics to orient yourself, and then exploring the specific topics that matter most to you right now.

Navigating Your Guide

01

Understanding Your MDS Diagnosis: First Steps

Recently diagnosed with Myelodysplastic Syndromes (MDS)? Learn about ineffective hematopoiesis, your IPSS-M risk score, and how to navigate watch and wait.

02

Recognizing the Symptoms of MDS

Learn how to recognize MDS symptoms. Understand the warning signs of anemia, low platelets, and low white blood cells, plus when to contact your doctor.

03

The Biology of MDS: Why Your Bone Marrow is Struggling

Learn the biology behind Myelodysplastic Syndromes (MDS). Understand ineffective hematopoiesis, stem cell mutations, and how doctors confirm an MDS diagnosis.

04

Subtypes and Behavior: Understanding Your MDS Category

Learn how to understand your MDS subtype, blast percentages, and genetic mutations. Discover what WHO classifications and IPSS-M risk scores mean for your care.

05

Deciphering Your Bone Marrow and Pathology Report

Learn how to read your MDS bone marrow pathology report. Understand blasts, karyotype, NGS panels, and what mutations like TP53 or SF3B1 mean for your care.

06

Advanced Risk Stratification: Understanding the IPSS-M

Learn how the IPSS-M scoring system uses your genetic data to predict your myelodysplastic syndrome (MDS) prognosis and guide your treatment options.

07

Standard Treatment Options for MDS

Learn about standard treatment options for Myelodysplastic Syndromes (MDS). Understand therapies for lower and higher-risk MDS, plus stem cell transplants.

08

Building Your Care Team and Preparing for Your First Visit

Learn how to build an expert Myelodysplastic Syndrome (MDS) care team, what records to bring to your first visit, and essential questions for your doctor.

09

Living with MDS: Monitoring and Quality of Life

Learn how to manage daily life with Myelodysplastic Syndromes (MDS). Discover tips for monitoring blood counts, preventing infection, and managing fatigue.

Common questions in this guide

What is the new name for Myelodysplastic Syndromes (MDS)?
Medical experts have officially updated the classification of Myelodysplastic Syndromes to Myelodysplastic Neoplasms. This name change reflects a more modern, precise understanding of the disease's underlying biology.
Does everyone with MDS need treatment right away?
No, not all patients require immediate treatment. Because MDS encompasses many different subtypes and risk levels, doctors often recommend a monitored 'watch and wait' approach for lower-risk forms of the disease.
What is the IPSS-M score for MDS?
The Molecular International Prognostic Scoring System (IPSS-M) is a modern tool used to predict how your specific MDS will behave. It analyzes 31 different genes to accurately determine your risk level and guide your treatment decisions.
How do doctors determine which subtype of MDS I have?
Your specific MDS subtype is determined through a detailed analysis of your bone marrow biopsy and pathology report. This testing identifies specific genetic mutations, like SF3B1, or chromosomal changes, like del(5q), that dictate how the disease behaves.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which of these resource pages should we review together first based on my specific situation?
  2. 2.Are there any topics covered in this guide that you believe don't apply to my specific subtype of MDS?
  3. 3.How can I best use this information to partner with you in making treatment decisions?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

This guide is for educational purposes only and does not replace professional medical advice. Always consult your hematologist or oncologist about your specific MDS diagnosis, IPSS-M score, and individualized treatment plan.

Get notified when new evidence is published on Myelodysplastic syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.